Biocare Hepaguard Forte Vegetable - Pack of 60 Capsules

Product Information

It is noteworthy that NAFLD is associated with metabolic syndrome (presence of three of the following factors: hypertension, raised triglycerides, lowered high‐density lipoprotein cholesterol, raised fasting glucose, central obesity) ( Alberti 2009; Ballestri 2016). A 'multiple parallel hits' model involving nutrition, gut bacteria, and accumulation of fat leading to liver inflammation has been proposed as an explanation for development and progression of NAFLD ( Tilg 2010; Buzzetti 2016). The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network. Data were sparse (zero events in all groups in the trial) for liver transplantation, liver decompensation, and hepatocellular carcinoma. The evidence is very uncertain about effects of interventions on serious adverse events (number of people or number of events).

Network meta‐analysis enables direct and indirect evidence to be combined and different interventions to be ranked in terms of different outcomes ( Salanti 2011; Salanti 2012). However, it must be noted that existing non‐invasive tests to distinguish NAFLD from alcohol‐related liver disease (ALD) are only about 75% to 90% accurate, and some individuals with ALD may be mis‐classified as having NAFLD ( Cerovic 2013; Wang 2016).The certainty of evidence was low or very low for all clinical outcomes because all trials included in the comparisons were at unclear or high risk of bias for at least one risk of bias domain at the outcome level (downgraded one level). If we found multiple records of the same trial, we collated all records related to the same study at the time of data extraction and obtained from these reports the following information as related to the study. This Review looked at people of any sex, age, and ethnic origin, with non‐alcohol‐related liver disease.

We summarised the population and methodological characteristics of trials included in the network meta‐analysis in a table based on pairwise comparisons. Major risk factors associated with increased prevalence of NAFLD are obesity, being male, increasing age, ethnicity (e. For each pairwise comparison in a table, we reported the fixed‐effect model if the two models reported similar results; otherwise, we reported the more conservative model (i. We propose registry‐based randomised clinical trials or cohort multiple randomised clinical trials (study design in which multiple interventions are trialed within large longitudinal cohorts of patients to gain efficiencies and align trials more closely to standard clinical practice) comparing interventions such as vitamin E, prebiotics/probiotics/synbiotics, PUFAs, and no nutritional supplementation. We excluded 24 records (21 studies) for the reasons stated under Characteristics of excluded studies.If the data were likely to be normally distributed, we used the median for meta‐analysis when the mean was not available; otherwise, we planned to simply provide a median and an interquartile range of the difference in medians. gov), the outcomes sought should have been those enumerated in the original protocol if the trial protocol had been registered before or at the time the trial was begun. Therefore, it is unlikely that differences in clinical outcomes can be noted in trials with less than 5 to 10 years of follow‐up.

Nutritional supplementation has the potential to result in resolution or decreased progression of fatty liver disease. A total of 60 trials were at low risk of attrition bias, as there were no post‐randomisation dropouts, or an intention‐to‐treat analysis was used; 129 trials were at unclear risk of attrition bias because it is not clear whether there were post‐randomisation dropouts, or whether post‐randomisation dropouts were related to outcomes (if there were post‐randomisation dropouts); the remaining 13 trials were at high risk of attrition bias, as post‐randomisation dropouts were probably related to the intervention and to outcomes. Various interventions have been used in attempts to treat people with NAFLD, including nutritional supplementation (probiotics, prebiotics, synbiotics, vitamin supplementation, polyunsaturated fatty acid supplementation) ( Nabavi 2014; Sharifi 2014; Li 2015; Nogueira 2016; Mofidi 2017); lifestyle modifications such as dietary changes and exercise training (not included in this review) ( Abenavoli 2015; Shojaee‐Moradie 2016; Zhang 2016; Houghton 2017); pharmacological interventions (not included in this review) ( Lombardi 2017); and weight reduction surgery (bariatric surgery) (not included in this review) for obese people with NAFLD ( Adorini 2012; Anstee 2012; Chalasani 2012; Paschos 2012; Abenavoli 2013). In comparisons involving clinical outcomes, the credible intervals were wide and overlapped significant clinical effect and no effect; therefore, we downgraded one more level for imprecision for comparisons with wide confidence intervals.BioCare Antioxidant Complex is a potent and synergistic combination of natural plant extracts including flavonoids and carotenoids, with alpha lipoic acid and vitamin C, providing optimum antioxidant support. We collected data at maximum follow‐up but also at short term (up to three months) and at medium term (from three months to five years) if these were available. Overall, downgrading of evidence resulted in very low certainty of evidence for all comparisons of clinical outcomes. Fatty liver disease is steatosis (accumulation of fat, usually triglycerides) in the liver parenchymal cells ( NCBI 2018). We estimated the probability that each intervention was ranked at each of the possible positions based on estimated effect sizes and their corresponding uncertainty using the NICE DSU codes ( Dias 2016).